[Active surveillance is a useful strategy in the management of patients with low-risk prostate cancer]

Ugeskr Laeger. 2014 Dec 8;176(50):V08140446.
[Article in Danish]

Abstract

Radical prostatectomy has in randomised settings failed to demonstrate a survival difference in patients with low-risk prostate cancer when tested against an observational strategy. Active surveillance has been introduced in order to reduce overtreatment by distinguishing between cancers with a biological potential, and truly indolent cancers best left untreated. Preliminary results from large prospective active surveillance cohorts are promising; however, uncertainties persist concerning optimal patient selection and follow-up, as well as the long-term safety.

Publication types

  • Review

MeSH terms

  • Disease Progression
  • Humans
  • Male
  • Neoplasm Grading
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms* / diagnosis
  • Prostatic Neoplasms* / therapy
  • Risk Assessment
  • Unnecessary Procedures
  • Watchful Waiting*

Substances

  • Prostate-Specific Antigen